AstraZeneca

A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden’s Astra and the UK’s Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.

All Articles

Astrazeneca has announced that it will sell the rights to its blockbuster cholesterol drug to German firm Gruenenthal GmbH for $320m (£240m).

Astrazeneca sells cholesterol drug to German firm for $320m

Astrazeneca has announced that it will sell the rights to its blockbuster cholesterol drug to German firm Gruenenthal GmbH for

December 1, 2020
Prime Minister Scott Morrison Announces Deal With AstraZeneca To Supply Potential COVID-19 Vaccine

Suspected North Korean hackers ‘target’ Covid-19 vaccine maker Astrazeneca

Suspected North Korean hackers are said to have made multiple attempts to hack into the computer systems of British Covid-19

November 27, 2020
Germany’s leading infectious disease institute said today a first vaccine against coronavirus could be available as early as autumn but warned that it may take longer to control the pandemic.

Government urges regulator to approve Astrazeneca-Oxford vaccine for emergency supply

The government has formally asked the UK’s medicines regulator to authorise Astrazeneca and Oxford University’s coronavirus vaccine for emergency supply.

November 27, 2020
Astrazeneca’s chief executive today said that the firm was likely to carry out another trial of its potential coronavirus vaccine after doubts were raised as to its efficacy.

Astrazeneca mulling extra vaccine trial to 'validate' efficacy after results confusion

Astrazeneca’s chief executive today said that the firm was likely to carry out another trial of its potential coronavirus vaccine

November 26, 2020
Astrazeneca’s chief executive today said that the firm was likely to carry out another trial of its potential coronavirus vaccine after doubts were raised as to its efficacy.

Analysis: Why dismay over the Astrazeneca vaccine is misplaced

Astrazeneca and the University of Oxford’s announcement this morning that their coronavirus vaccine proved 70 per cent effective in late-stage

November 23, 2020
The lead developer of the University of Oxford's coronavirus vaccine has said that it is possible that it will be rolled out by the end of the year.

Could anti-vaxxers be barred from offices, pubs and gyms?

Banning Covid vaccine refusers from offices, restaurants and other venues may lead to expensive discrimination claims, a leading lawyer has

November 22, 2020

Which Covid vaccines has the UK government ordered?

The global race for a coronavirus vaccine received another boost today as US biotech firm Moderna announced its Covid jab

November 16, 2020

Coronavirus: Phase one vaccine rollout will protect ‘99 per cent’ of UK's at-risk population

The UK’s top health officials today announced the priority list for vaccination against coronavirus, after health secretary Matt Hancock yesterday

November 11, 2020
Pharma giant Astrazeneca has seen its sales and revenue rise for the year to date despite the ongoing disruption from the coronavirus pandemic.

Astrazeneca boosts revenue but misses first vaccine delivery target

Pharma giant Astrazeneca has seen its sales and revenue rise for the year to date despite the ongoing disruption from

November 5, 2020

Coronavirus: NHS boss confirms health service is preparing for vaccine by Christmas

The NHS is preparing to distribute potential Covid-19 vaccines in time for Christmas, the head of the health service announced

November 4, 2020
Weekly outlook: FTSE heavyweights in spotlight as election day arrives

Weekly outlook, 2-6 November: FTSE heavyweights in spotlight as election day arrives

It’s election day at last, and while the outcome of Tuesday’s vote in the US will drive the headlines for

November 2, 2020
The UK’s drugs regulator has begun an accelerated review of coronavirus vaccine candidates developed by Astrazeneca and Pfizer.

Astrazeneca and Pfizer vaccines under accelerated review by drugs regulator

The UK’s drugs regulator has reportedly begun an accelerated review of coronavirus vaccine candidates developed by Astrazeneca and Pfizer. Bloomberg

October 30, 2020

Content tagged with "AstraZeneca"